Grifols, S.A. (GRFS)
Pre-market:
| Previous close | 6.58 |
| Open | 6.64 |
| Bid | 6.52 x 800 |
| Ask | 6.55 x 800 |
| Day's range | 6.46 - 6.64 |
| 52-week range | 5.30 - 12.15 |
| Volume | |
| Avg. volume | 2,169,737 |
| Market cap | 5.567B |
| Beta (5Y monthly) | 0.68 |
| PE ratio (TTM) | 65.40 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 03 June 2021 |
| 1y target est | N/A |
- Reuters
Spanish drug maker Grifols will bring in independent directors, chairman tells newspaper
MADRID (Reuters) -Spanish drug maker Grifols, battling a plunge in its share price this year, plans to add independent directors to its audit and compensation committees to improve its governance, its chairman said in a newspaper interview published on Sunday. Grifols' market value has shed billions of euros since short-sheller Gotham City Research released three reports in early January accusing the company of overstating earnings and understating debt. Grifols has repeatedly denied the claims.
- Bloomberg
Grifols Plans First Bond Sale Since Short Seller Attack
(Bloomberg) -- Grifols SA is seeking to issue a new bond, in what would be its first debt deal since coming under attack from a short seller in January.Most Read from BloombergUS Slams Strikes on Russia Oil Refineries as Risk to Oil MarketsUS Core CPI Tops Forecasts Again, Likely Delaying Fed Rate CutsChinese Cement Maker Halted After 99% Crash in 15 MinutesBond Trader Places Record Futures Bet on Eve of Inflation DataApple’s India iPhone Output Hits $14 Billion in China ShiftThe Barcelona-based
- Bloomberg
Grifols Drops as Regulator Finds ‘Relevant Deficiencies’
(Bloomberg) -- Grifols SA shares dropped as investors evaluated a regulatory review of the Spanish bio-science company’s financial reports, which found “relevant deficiencies” but no major accounting mistakes.Most Read from BloombergNY Gears Up to Seize Trump Westchester Assets If Fraud Fine Is UnpaidBaltimore Wants to Sell Hundreds of Vacant Homes for $1 EachWhat Happens If Trump Can’t Post His $454 Million BondChina Scrutinizes PwC Role in $78 Billion Evergrande Fraud CaseYemen’s Houthis Tell
